Variant report
Variant | nsv2831 |
---|---|
Chromosome Location | chr2:95618109-95662330 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:95613600-95620800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr2:95618800-95619000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr2:95618800-95619000 | Flanking Bivalent TSS/Enh | Esophagus | oesophagus |
4 | chr2:95619000-95619400 | Flanking Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
5 | chr2:95619000-95619600 | Bivalent/Poised TSS | Primary T cells fromperipheralblood | blood |
6 | chr2:95619000-95619600 | Active TSS | Fetal Thymus | thymus |
7 | chr2:95621000-95622400 | Enhancers | Brain Germinal Matrix | brain |
8 | chr2:95622400-95622600 | Bivalent Enhancer | Brain Angular Gyrus | brain |
9 | chr2:95623000-95623200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr2:95624800-95625000 | Bivalent Enhancer | Pancreatic Islets | Pancreatic Islet |
11 | chr2:95624800-95627000 | Enhancers | Fetal Lung | lung |
12 | chr2:95627000-95629200 | Weak transcription | Fetal Lung | lung |
13 | chr2:95629200-95629400 | Enhancers | Fetal Lung | lung |
14 | chr2:95637000-95637400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr2:95637200-95637600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr2:95637200-95638200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr2:95637400-95637800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr2:95637800-95647600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr2:95642600-95642800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
20 | chr2:95643400-95643600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
21 | chr2:95646000-95646200 | Enhancers | Esophagus | oesophagus |
22 | chr2:95646200-95647600 | Weak transcription | Esophagus | oesophagus |
23 | chr2:95647600-95647800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
24 | chr2:95647600-95648600 | Enhancers | Esophagus | oesophagus |
25 | chr2:95647800-95650600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
26 | chr2:95648000-95648800 | Enhancers | Fetal Thymus | thymus |
27 | chr2:95648400-95648800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
28 | chr2:95648400-95648800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
29 | chr2:95648400-95648800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
30 | chr2:95648400-95648800 | Enhancers | Primary hematopoietic stem cells | blood |
31 | chr2:95648400-95648800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
32 | chr2:95648400-95648800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
33 | chr2:95648400-95649200 | Enhancers | HSMMtube | muscle |
34 | chr2:95648600-95649200 | Weak transcription | Esophagus | oesophagus |
35 | chr2:95648800-95650600 | Weak transcription | Fetal Thymus | thymus |
36 | chr2:95648800-95651000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
37 | chr2:95649200-95649400 | Enhancers | Esophagus | oesophagus |
38 | chr2:95649400-95650200 | Weak transcription | Esophagus | oesophagus |
39 | chr2:95650200-95650400 | Enhancers | Esophagus | oesophagus |
40 | chr2:95650400-95650800 | Weak transcription | Esophagus | oesophagus |
41 | chr2:95650600-95651000 | Enhancers | Fetal Thymus | thymus |
42 | chr2:95650600-95651200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
43 | chr2:95650800-95651600 | Enhancers | Esophagus | oesophagus |
44 | chr2:95651000-95651200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
45 | chr2:95651000-95651200 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
46 | chr2:95651000-95652200 | Weak transcription | Fetal Thymus | thymus |
47 | chr2:95651200-95660600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
48 | chr2:95651600-95660600 | Weak transcription | Esophagus | oesophagus |
49 | chr2:95652200-95652400 | Enhancers | Fetal Thymus | thymus |
50 | chr2:95652400-95652800 | Weak transcription | Fetal Thymus | thymus |